Search Results

An Interview With Professor Thomas Zeller, MD

The Director of the Department of Angiology at Universitaets-Herzzentrum talks data on renal denervation, drug-eluting balloons, and other recent trials.

Global Perspectives on SFA Treatment: Germany

By Thomas Zeller, MD

Collaborative, Comprehensive CLI Treatment

By Jihad A. Mustapha, MD, and Prof. Thomas Zeller, MD

The LifeStent Studies

An overview of the trials studying bare-metal stents in the superficial femoral and popliteal artery.

By Thomas Zeller, MD

Applying Atherectomy in CLI Patients

A review of atherectomy modalities for treating critical limb ischemia and a look at the remaining challenges to overcome.

By Thomas Zeller, MD, and Lawrence A. Garcia, MD

Drug-Coated Balloons Below the Knee: What Have We Learned?

Nearly a year and a half after the surprising trial results were presented, IN.PACT DEEP Principal Investigator, Prof. Thomas Zeller, MD, addresses lingering questions on DCBs in BTK lesions.

Ask the Experts: Based on the tibial DCB trials, is there light at the end of the tunnel?

With Thomas Zeller, MD; J.A. Mustapha, MD; and Marianne Brodmann, MD

Drug-Coated Balloons: Hope or Hype?

A stentless technology is an attractive option if it achieves at least as good acute and long-term results as current devices in the femoropopliteal artery.

By Thomas Zeller, MD

Panel Discussion: Exploring the Paclitaxel Safety Signal

Experts discuss considerations in trial design, adjudication, and paths forward.

With Marianne Brodmann, MD; William Gray, MD; Peter A. Schneider, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Thomas Zeller, MD, PhD

Roundtable Discussion: The Challenges of Extreme Femoropopliteal Calcification

Global perspectives on the current landscape for the treatment of extreme calcification.

Moderator: William A. Gray, MD;
Panelists: Marianne Brodmann, MD; Manar Khashram, MBChB, PhD, FRACS; Andrej Schmidt, MD; and Thomas Zeller, MD

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD